New hope for liver cancer patients who run out of options
Disease control
Recruiting now
This study is testing a new drug called AST-3424 for people with advanced liver cancer that has gotten worse despite treatment with modern immunotherapy drugs. It aims to see if this new drug can help patients live longer. Researchers will compare it directly to another available…
Phase: PHASE2 • Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC